722 reports of this reaction
1.3% of all VALPROIC ACID reports
#14 most reported adverse reaction
STATUS EPILEPTICUS is the #14 most commonly reported adverse reaction for VALPROIC ACID, manufactured by Actavis Pharma, Inc.. There are 722 FDA adverse event reports linking VALPROIC ACID to STATUS EPILEPTICUS. This represents approximately 1.3% of all 57,615 adverse event reports for this drug.
VALPROIC ACID has an overall safety score of 92 out of 100. Patients taking VALPROIC ACID who experience status epilepticus should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
STATUS EPILEPTICUS is a less commonly reported adverse event for VALPROIC ACID, but still significant enough to appear in the safety profile.
In addition to status epilepticus, the following adverse reactions have been reported for VALPROIC ACID:
The following drugs have also been linked to status epilepticus in FDA adverse event reports:
STATUS EPILEPTICUS has been reported as an adverse event in 722 FDA reports for VALPROIC ACID. This does not prove causation, but indicates an association observed in post-market surveillance data.
STATUS EPILEPTICUS accounts for approximately 1.3% of all adverse event reports for VALPROIC ACID, making it a notable side effect.
If you experience status epilepticus while taking VALPROIC ACID, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.